Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1800 | 2410 | 40.4 | 74% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CATHEPSIN B | Author keyword | 143 | 36% | 13% | 316 |
2 | CATHEPSIN L | Author keyword | 90 | 39% | 8% | 183 |
3 | CATHEPSIN X | Author keyword | 40 | 76% | 1% | 28 |
4 | PROCATHEPSIN L | Author keyword | 35 | 89% | 1% | 16 |
5 | CATHEPSIN S | Author keyword | 31 | 22% | 5% | 124 |
6 | CYSTEINE CATHEPSINS | Author keyword | 30 | 68% | 1% | 26 |
7 | CATHEPSIN | Author keyword | 30 | 20% | 6% | 134 |
8 | BIOCHEM DRUG DESIGN | Address | 27 | 70% | 1% | 23 |
9 | CATHEPSIN H | Author keyword | 26 | 57% | 1% | 31 |
10 | CYSTEINE PROTEASE | Author keyword | 25 | 17% | 6% | 136 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CATHEPSIN B | 143 | 36% | 13% | 316 | Search CATHEPSIN+B | Search CATHEPSIN+B |
2 | CATHEPSIN L | 90 | 39% | 8% | 183 | Search CATHEPSIN+L | Search CATHEPSIN+L |
3 | CATHEPSIN X | 40 | 76% | 1% | 28 | Search CATHEPSIN+X | Search CATHEPSIN+X |
4 | PROCATHEPSIN L | 35 | 89% | 1% | 16 | Search PROCATHEPSIN+L | Search PROCATHEPSIN+L |
5 | CATHEPSIN S | 31 | 22% | 5% | 124 | Search CATHEPSIN+S | Search CATHEPSIN+S |
6 | CYSTEINE CATHEPSINS | 30 | 68% | 1% | 26 | Search CYSTEINE+CATHEPSINS | Search CYSTEINE+CATHEPSINS |
7 | CATHEPSIN | 30 | 20% | 6% | 134 | Search CATHEPSIN | Search CATHEPSIN |
8 | CATHEPSIN H | 26 | 57% | 1% | 31 | Search CATHEPSIN+H | Search CATHEPSIN+H |
9 | CYSTEINE PROTEASE | 25 | 17% | 6% | 136 | Search CYSTEINE+PROTEASE | Search CYSTEINE+PROTEASE |
10 | STEFINS | 17 | 68% | 1% | 15 | Search STEFINS | Search STEFINS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MAJOR EXCRETED PROTEIN | 63 | 78% | 2% | 42 |
2 | CYSTEINE PROTEINASES | 50 | 18% | 10% | 243 |
3 | INHIBITORS STEFIN A | 44 | 78% | 1% | 29 |
4 | PROCATHEPSIN B | 43 | 57% | 2% | 50 |
5 | MULTISTAGE TUMORIGENESIS | 41 | 61% | 2% | 43 |
6 | PAPAIN FAMILY | 38 | 89% | 1% | 17 |
7 | PAPAIN | 36 | 20% | 7% | 167 |
8 | OCCLUDING LOOP | 33 | 66% | 1% | 31 |
9 | CYSTEINE CATHEPSINS | 32 | 31% | 4% | 85 |
10 | PROCATHEPSIN L | 31 | 48% | 2% | 48 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Cysteine cathepsins: From structure, function and regulation to new frontiers | 2012 | 136 | 334 | 51% |
Intracellular signaling by cathepsin X: Molecular mechanisms and diagnostic and therapeutic opportunities in cancer | 2015 | 2 | 78 | 59% |
Lysosomal cysteine proteases: more than scavengers | 2000 | 451 | 142 | 57% |
Cathepsin B as a cancer target | 2013 | 26 | 104 | 53% |
Lysosomal cysteine proteases: facts and opportunities | 2001 | 421 | 39 | 56% |
Cysteine cathepsins: multifunctional enzymes in cancer | 2006 | 479 | 134 | 45% |
Cysteine cathepsin proteases as pharmacological targets in cancer | 2008 | 121 | 59 | 54% |
Cysteine cathepsins and extracellular matrix degradation | 2014 | 14 | 211 | 44% |
Emerging roles of cysteine cathepsins in disease and their potential as drug targets | 2007 | 167 | 206 | 39% |
Cysteine cathepsins in human cancer | 2004 | 140 | 112 | 82% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOCHEM DRUG DESIGN | 27 | 70% | 1.0% | 23 |
2 | GENET TOXICOL CANC BIOL | 10 | 27% | 1.3% | 31 |
3 | BIOCHEM MOL STRUCT BIOL | 5 | 16% | 1.2% | 30 |
4 | UROL UROL SURG | 4 | 67% | 0.2% | 4 |
5 | MOL MED ZELLFOR | 4 | 18% | 0.9% | 22 |
6 | MOL MED CELL | 4 | 11% | 1.2% | 29 |
7 | CLIN CHEM BACTERIOL | 3 | 57% | 0.2% | 4 |
8 | MOL CELLULAR PNEUMOL | 3 | 57% | 0.2% | 4 |
9 | LUDWIG HEILMEYER COMPREHENS CANC | 3 | 100% | 0.1% | 3 |
10 | CLIN PNEUMOL CHEST SURG | 3 | 50% | 0.2% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000228799 | CATHEPSIN K//PYCNODYSOSTOSIS//CATHEPSIN K INHIBITOR |
2 | 0.0000227621 | CYSTATIN//HUMAN CYSTATIN C//CYSTEINE PROTEINASE INHIBITOR |
3 | 0.0000167109 | CATHEPSIN D//PROCATHEPSIN D//UNITE HORMONES CANC |
4 | 0.0000127889 | CALPAIN CATHEPSIN HYPOTHESIS//OSMOTIC SENSITIVITY//LYSOSOME STABILITY |
5 | 0.0000109363 | CRUZAIN//PLASMEPSIN//CRUZIPAIN |
6 | 0.0000092310 | PLANT ENDOPEPTIDASE//BROMELAIN//CARICA CANDAMARCENSIS |
7 | 0.0000068083 | UVEAL INFLAMMATION//IRIS CILIARY COMPLEX//OCULAR TISSUE |
8 | 0.0000061069 | PAPILLON LEFEVRE SYNDROME//HAIM MUNK SYNDROME//CATHEPSIN C |
9 | 0.0000046857 | CHEMICAL PROTEOMICS//ACTIVITY BASED PROTEIN PROFILING//PLANT CHEMET |
10 | 0.0000044985 | ANTILIPOLYTIC DRUGS//CELLULAR AUTOPHAGY//CHAPERONE MEDIATED AUTOPHAGY |